Your Heart Rate Seems Normal, but Your Genes May Be Extending It Dangerously.

Your heart’s electrical signal begins with a surge of sodium into heart muscle cells. SCN5A encodes the main sodium channel (Nav1.5) that makes this rush possible. When sodium floods in, the cell membrane depolarizes and the electrical impulse spreads across your heart, triggering a heartbeat. Then the channel closes, and potassium flows out to reset the signal. This on-off timing is critical.

SCN5A variants come in two main flavors: loss-of-function and gain-of-function. Loss-of-function variants reduce sodium influx, delaying the electrical signal and lengthening the QT interval. Gain-of-function variants allow sodium to leak in even when the channel should be closed, creating abnormal activity. SCN5A variants account for roughly 10-15% of inherited long QT cases. They are often severe and require careful management.

If you carry an SCN5A variant, your heart’s primary electrical switch is compromised. The signal may move too slowly (loss of function) or may fire at the wrong time (gain of function). Either way, your QT interval stretches beyond safe limits. Physical stress, fever, and sleep can all trigger dangerous rhythms in people with SCN5A variants. This is why some people with long QT have events during exercise or fever while others have them at night. Your specific SCN5A variant determines your trigger.

After sodium enters a heart cell and depolarizes it, potassium must flow out to reset the electrical signal. KCNQ1 encodes the slow potassium channel (IKs) that performs this critical reset. Without proper potassium outflow, your heart cell stays depolarized too long. The QT interval stretches. The electrical signal doesn’t reset in time for the next beat.

KCNQ1 variants are the most common genetic cause of long QT syndrome, accounting for roughly 40-50% of genetically confirmed long QT cases. Most variants are loss-of-function, meaning they reduce potassium flow. Some are dominant (you need only one copy to have the disease); some are recessive (you need two copies, and this severe form is called Jervell and Lange-Nielsen syndrome, which includes deafness). The prevalence varies by ancestry, but roughly 1 in 2,500 people carry a pathogenic KCNQ1 variant.

If you have a KCNQ1 variant, your heart cannot reset its electrical signal quickly enough, and that delay is encoded in your DNA. Stress, swimming, auditory stimuli, and sleep can all trigger dangerous heart rhythms. Women with KCNQ1 variants often have more dangerous events during pregnancy and the postpartum period due to hormonal effects on ion channels.

Nitric oxide (NO) is a signaling molecule that tells blood vessels to relax and dilate. When NOS3 (endothelial nitric oxide synthase) works well, it produces steady NO, your blood vessels stay supple, and your heart doesn’t have to work so hard. NOS3 also has direct effects on heart muscle cells, stabilizing their electrical properties. The Glu298Asp variant in NOS3 reduces the enzyme’s activity.

The Glu298Asp variant is carried by roughly 30-40% of people with European ancestry. In most, it causes no obvious problem. But in people with long QT syndrome or with other cardiovascular risk factors, reduced NO production becomes a liability. Your blood vessels become less able to dilate when your heart demands more blood flow, and your heart’s electrical cells lose some of their natural stabilization. During exercise or emotional stress, this limitation matters most.

You experience this as reduced exercise tolerance, or as heart rhythm irregularities during exertion. Your blood pressure may rise more easily. Your heart works harder to deliver the same blood flow. Over time, the chronic strain on your heart increases the risk of arrhythmias. The effect is subtle in young, healthy people but becomes pronounced as you age or add other stressors.

Your blood pressure is controlled partly by a hormone system called the renin-angiotensin-aldosterone system (RAAS). ACE (angiotensin-converting enzyme) is the critical step in this cascade. It converts angiotensin I into angiotensin II, a powerful vasoconstrictor that tells blood vessels to squeeze and raises blood pressure. The ACE gene has a common insertion/deletion polymorphism (I/D). People with the D/D genotype produce more ACE activity.

The D/D genotype is present in roughly 25% of people with European ancestry. These individuals have higher baseline ACE activity, higher angiotensin II levels, and higher blood pressure. Over time, the constant high blood pressure and high angiotensin II drive changes in heart muscle itself: the left ventricle thickens (left ventricular hypertrophy). A thickened, stiffened heart muscle is prone to electrical instability. The risk of arrhythmias,including QT prolongation,increases significantly.

If you have the D/D genotype, your heart is fighting against chronically elevated angiotensin II. You may notice higher baseline blood pressure, especially with stress or salt intake. Your heart has to work harder, which can trigger arrhythmias during exertion. The longer you live with this imbalance, the more structural changes accumulate in your heart.

Homocysteine is an amino acid that, at high levels, damages blood vessel walls and increases thrombosis risk. Your body breaks down homocysteine using folate (vitamin B9) as a cofactor. MTHFR (methylenetetrahydrofolate reductase) is the enzyme that converts dietary folate into its active form. If MTHFR is inefficient, folate doesn’t convert properly, homocysteine accumulates, and your blood vessels suffer.

The MTHFR C677T variant is carried by roughly 40% of people with European ancestry. The T allele reduces enzyme efficiency by 40-70%. People homozygous for the T allele (C677T/C677T) have measurably elevated homocysteine, even on a good diet. Elevated homocysteine promotes atherosclerosis, stiffens blood vessels, and increases the risk of clot formation. All of these create electrical instability in the heart.

You may not feel elevated homocysteine directly. But it shows up as early blood vessel aging, high blood pressure, and increased arrhythmia risk. If you have long QT syndrome and elevated homocysteine (from an MTHFR variant), you have a double hit: your ion channels are electrically unstable and your blood vessels are chronically inflamed.

Your nervous system uses epinephrine (adrenaline) and norepinephrine to ramp up your heart rate and blood pressure during stress. COMT (catechol-O-methyltransferase) is the enzyme that clears these stress hormones from your body once the threat passes. If COMT is slow, these hormones linger, keeping you in a heightened state of arousal. Your heart rate stays elevated. Your blood vessels stay constricted. Your heart’s electrical system becomes oversensitized.

The COMT Val158Met variant affects enzyme speed. Roughly 25% of people with European ancestry are homozygous for the slow Met allele. Slow COMT means your stress hormones clear slowly, prolonging the fight-or-flight response even after the stressor is gone. Your baseline blood pressure creeps up. Your heart’s electrical threshold for triggering arrhythmias drops. You feel perpetually ready to run.

You experience this as high baseline anxiety, caffeine sensitivity, and a hair-trigger heart rate during stress. Your heart may race even from mild provocation. In people with long QT syndrome, this stress sensitivity is dangerous because emotional stress can trigger QT-prolonging arrhythmias. The longer your stress hormones stay elevated, the higher your rhythm risk.